Bal Pharma standalone net profit declines 38.83% in the September 2017 quarter

Sales decline 16.74% to Rs 54.55 crore

Net profit of Bal Pharma declined 38.83% to Rs 1.67 crore in the quarter ended September 2017 as against Rs 2.73 crore during the previous quarter ended September 2016. Sales declined 16.74% to Rs 54.55 crore in the quarter ended September 2017 as against Rs 65.52 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales54.5565.52 -17 OPM %10.109.28 -PBDT4.085.27 -23 PBT2.333.87 -40 NP1.672.73 -39

Powered by Capital Market - Live News